Clinical trial · Observational
Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor
Remote Vital Sign Monitoring in Palliative Care - VITAL-PC
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer admitted to a hospice inpatient unit for end-of-life care. The objectives of the study are: 1. could remote monitoring of vital signs improve patient care through the earlier identification of infections and other (potentially reversible) problems; 2. could remote monitoring of vital signs improve the accuracy of our estimates about how long a person has to live; and c) determine the relationship between complaints of pain / other symptoms and vital signs.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Hospice | — | UNRESOLVED | — |
| Malignancies Multiple | — | UNRESOLVED | — |
| Terminal Care | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Palliative Care Patients
- description
- Patients admitted to the specialist palliative care unit with a primary diagnosis of malignant disease
Primary outcomes (1)
- measure
- Mean, standard deviation, median, and range of heart rate variability (HRV) at predefined time intervals prior to death
- timeFrame
- From device initiation until death (up to 14 days), with analysis conducted across predefined time intervals prior to death
- description
- Summary statistics (mean, standard deviation, median, and range) of heart rate variability defined as the Root Mean Square of Successive Differences (RMSSD), measured using a wearable ECG patch at predefined time intervals prior to death (0-24 hours, 24-48 hours, 48-72 hours, 72 hours-7 days, and 7-14 days).
Secondary outcomes (5)
- measure
- Mean, standard deviation, median, and range of heart rate at predefined time intervals prior to death
- timeFrame
- From device initiation until death (up to 14 days), with analysis conducted across predefined time intervals prior to death
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years old * Primary diagnosis of malignant disease * Admitted for end-of-life care (or focus of care changed to end-of-life care) * Estimated prognosis \< 14 days Exclusion Criteria: * Primary diagnosis of non-malignant disease * Inability to provide informed consent * Contraindications to use of biosensor adhesive patch (e.g. chest wall skin problem, allergy to adhesive)
References
Publications (5)
- BACKGROUNDPower J, Gouldthorpe C, Davies A. Vital Signs in Palliative Care: A Scoping Review. Cancers (Basel). 2023 Sep 20;15(18):4641. doi: 10.3390/cancers15184641. PMID 37760611
- BACKGROUNDSeymour JE. Revisiting medicalisation and 'natural' death. Soc Sci Med. 1999 Sep;49(5):691-704. doi: 10.1016/s0277-9536(99)00170-7. PMID 10452423
- BACKGROUNDEllershaw J, Wilkinson S. Care of the dying. a pathway to excellence. Oxford University Press: Oxford, UK; 2003.
- BACKGROUNDVeerbeek L, van Zuylen L, Swart SJ, van der Maas PJ, van der Heide A. The last 3 days of life in three different care settings in The Netherlands. Support Care Cancer. 2007 Oct;15(10):1117-23. doi: 10.1007/s00520-006-0211-x. Epub 2007 Mar 15. PMID 17357794
- BACKGROUNDOlsson T, Terent A, Lind L. Rapid Emergency Medicine score: a new prognostic tool for in-hospital mortality in nonsurgical emergency department patients. J Intern Med. 2004 May;255(5):579-87. doi: 10.1111/j.1365-2796.2004.01321.x. PMID 15078500